Pharmacy Clinical Specialist - Lymphoma/Myeloma
About the job
- A Doctor of Pharmacy or Bachelor of Science in Pharmacy from an accredited college of pharmacy is required.
- Specialty residency training is required when hired for a specialty area where such training is available.
- Current state licensure as a Registered Pharmacist, or eligibility for reciprocation in the current state within 90 days of hire, is required.
- Completion of a postgraduate year 2 residency or fellowship, or completion of a postgraduate year 1 residency and two years of experience as a clinical specialist or equivalent role providing pharmaceutical care and performing pharmaceutical monitoring, or four years of experience as a clinical specialist or equivalent role providing pharmaceutical care and performing pharmacotherapeutic monitoring, is required.
- For individuals required to administer immunizations, current Basic Life Support certification through the American Heart Association or American Red Cross and completion of a Board of Pharmacy-approved immunization administration course or certification within 90 days of hire are required.
- For individuals required to respond to adult or pediatric cardiopulmonary arrest events, current Advanced Cardiovascular Life Support or Pediatric Advanced Life Support certification through the American Heart Association or American Red Cross, or certification within one year of hire, is required.
- The role requires the ability to stand and walk for prolonged periods, approximately 75% of the shift, and continuously for extended periods.
- Manual dexterity sufficient for computer and dispensing functions and the ability to lift up to 30 pounds are required.
- The role requires reaching, stretching, stooping, climbing steps, sitting, and normal or corrected vision.
- The role requires clear verbal communication by phone or in person.
- Standard precautions and required personal protective equipment must be followed.
- Compliance with the annual influenza prevention program, including vaccination or an approved exemption, is required.
- Coordinate and provide pharmaceutical care for patients.
- Participate in patient care rounds.
- Perform pharmacotherapeutic monitoring and provide pharmaceutical care for patients.
- Provide general and patient-specific drug information.
- Educate clinical pharmacists, technicians, pharmacy students, postgraduate trainees, allied health professionals, nurses, and physicians in pharmacotherapy.
- Support oncology patients across inpatient and outpatient settings.
- Rotate through the inpatient lymphoma and myeloma service, outpatient lymphoma clinic, and outpatient myeloma clinic.
- Lead chemotherapy-related decision-making and Beacon order verification.
- Manage discharge and consult services.
- Collaborate with inpatient, outpatient, and specialty pharmacy teams to ensure safe and seamless transitions of care.
- Perform proactive chart review, prepare and validate complex chemotherapy regimens, coordinate planned admissions, provide patient education and drug information support, and participate in pharmacist consult services to optimize therapy across the continuum of care.
- Precept learners and conduct or lead research.
- Board certification.
About the company
Cleveland Clinic is a non-profit academic medical center that provides medical care, conducts research, and educates future clinicians. It offers in-person and virtual care, including routine check-ups, specialized treatments, surgeries, second opinions, and tools like MyChart for managing health records. It differentiates itself by combining patient care with broad research, education, and digital tools, plus a global network and provider services like DrConnect and eRadiology. Its goal is to improve health outcomes by delivering high-quality care while expanding access and advancing medical knowledge worldwide.
Company Size
10,001+
Company Stage
Grant
Total Funding
$74.7M
Headquarters
Cleveland, Ohio
Founded
1921
Get referred to Cleveland Clinic
See people who can refer or advise you
Simplify's Take
What believers are saying
- 2026 grant wins include NIH's $21.1 million Alzheimer's award on September 16.
- 2025 operating revenue reached $18 billion, with 2026 Q1 margin at 3.7%.
- Ambience deployed across outpatient practices in 2025, reducing clinician documentation burden.
What critics are saying
- June 2026 DOJ pressure forced a 20-year pause on pediatric gender-affirming care.
- January 2025 layoffs cut 114 administrative jobs, signaling cost pressure and weak overhead control.
- Weatherly v. Cleveland Clinic filed December 2025 attacks website tracking and patient privacy.
What makes Cleveland Clinic unique
- Cleveland Clinic's 2025-2026 AI stack spans Ambience, Palantir, Oracle, and Luminai.
- Its 2025-2026 quantum partnership with IBM and RIKEN targets drug discovery.
- The Regent Surgical JV puts Cleveland Clinic on outpatient surgery-center ownership.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Professional Development Budget
Mental Health Support
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
0%Our technology ventures allow entrepreneurs, healthcare startups and venture firms to invest in inventions from leading clinicians and researchers.
Ayble Health, an AI-enabled virtual digestive health clinic, has closed an oversubscribed $16 million Series A round led by Neon. The funding brings the Boston-based company's total capital raised to over $27 million. The company plans to expand its services beyond gastrointestinal conditions into autoimmune health. Ayble now covers 80 million Americans through partnerships with payers, employers, and health systems, and is in-network with most commercial health plans. Ayble's multidisciplinary care model combines GI specialists, dietitians, behavioural health experts, and AI technology. The company has published 16 peer-reviewed clinical studies and reports an average 47% improvement in GI symptoms for patients within four weeks. Founder Sam Jactel, who has inflammatory bowel disease, said the funding will deepen AI precision care capabilities whilst extending services to autoimmune conditions.
Cleveland Clinic has rolled out ambient AI scribes to approximately 5,000 providers following a successful pilot programme. The technology records, transcribes and summarises patient-physician conversations, reducing documentation time by two minutes per appointment and 14 minutes daily. In 2024, 250 physicians tested five ambient listening products. Cleveland Clinic selected Ambience's AI platform, and within 15 weeks of launch, 4,000 clinicians were actively using it. The system is now expected to document one million patient encounters by August 2025, with physicians using it for roughly 76% of scheduled office visits. The AI adapts to medical specialties and requires patient consent and physician review before entering electronic health records. Chief Digital Officer Rohit Chandra said the technology has restored "joy" to caregiving by reducing administrative burden.
Scientists at Cleveland Clinic, RIKEN and IBM have simulated protein complexes of up to 12,635 atoms using quantum computers — the largest-known simulations of biologically meaningful molecules performed with quantum hardware. The achievement signals quantum computers are maturing into useful scientific tools for biology, chemistry and life sciences research. The breakthrough was enabled by a novel algorithm that optimises collaboration between quantum and classical computers, a framework called quantum-centric supercomputing. The team captured the behaviour of two biochemically relevant proteins roughly 40 times larger than what the same method could achieve six months ago, whilst improving accuracy by up to 210 times. The research used IBM's 156-qubit Quantum Heron processors at Cleveland Clinic and RIKEN, working alongside supercomputers Fugaku and Miyabi-G, to model molecular systems relevant to drug discovery.
Cleveland Clinic has partnered with Luminai, a San Francisco-based AI startup, to automate complex administrative healthcare workflows. The collaboration coincides with Luminai's $38 million Series B funding round, bringing total capital raised to approximately $60 million, with backing from Peak XV Partners, General Catalyst, Define Ventures and Y Combinator. The health system, which employs over 80,000 staff across 23 hospitals, selected Luminai to address administrative burdens that account for roughly a quarter of US healthcare spending. Initial deployment focuses on referral management, where Cleveland Clinic processes thousands of daily faxes requiring manual review and routing. "The goal is to reduce administrative burden and allow our caregivers to focus on patient care," said Rohit Chandra, Cleveland Clinic's chief digital officer. The partnership reflects growing pressure on health systems to modernise operations whilst managing workforce shortages and rising costs.